Introduction
Human CRTH2 gene encoding a chemoattractant receptor is selectively expressed on Th2 cells, basophils, and eosinophils. [1] [2] [3] CRTH2 is a novel receptor for prostaglandin (PGD 2 ), an important mediator in the regulation of inflammatory responses, and has been implicated in the regulation of allergic inflammation. 4 The gene for CRTH2 is located in chromosome 11q12, a region showing linkage to asthma and asthma-associated phenotypes (for review see Hakonarson and Wjst 5 ). Using a sequencing strategy, 6 we have identified three novel SNPs in the CRTH2 gene and confirmed an in silico SNP dbSNP ID:rs545659), following a systematic screen of the exon, exon-intron boundary, 5Ј-and 3Ј-UTR sequences in a Chinese population.
Results
Following sequencing of pooled DNA samples, a total of four sequence variants were identified and each of the four SNPs was genotyped for the entire study population of 65 individuals. Two common SNPs (SNP#1 and #2) with a G to C and an A to G substitution at position 1544 and 1651 (based on GenBank sequence XM006046), respectively, were identified in the 3Ј-UTR region (see Figure 1 for representation). As shown in Table 1 , for SNP#1, the most frequent genotype was GG (75%) and for SNP#2, AG (49.09%). SNP#2 was identical to a variant previously found in silico and deposited in NCBI SNP database (dbSNP ID: rs545659). Two coding-region SNPs with a T to G (SNP#3) and a C to A (SNP#4) substitutions at position 179 and 197, respectively, were also discovered, although these substitutions were relatively rare. These variant sequences resulted in changes in aminoacid residues from Phe to Val and Pro to Thr, respectively (based on GenBank sequence AF118265 and its predicted reading frame).
Interaction of the CRTH2 gene product and its natural ligand, PGD 2 , has been suggested to be important in inflammatory cell recruitment and activation. [1] [2] [3] [4] These functional studies together with its physical location in chromosome 11q12-13, a region where linkage to asthma and asthma-associated traits have been demonstrated, 5 suggest therefore that CRTH2 gene is a candidate gene for allergic diseases, and that newly identified SNPs will be informative for genetic studies of asthma and other immunologic diseases.
Methods
A total of 65 subjects were recruited at our pediatric clinic of Chang Gung Children's Hospital, Taoyuan, Taiwan, ROC, and 40 out of 65 subjects had physician-diagnosed asthma. Genomic DNAs were purified from peripheral blood mononuclear cells of each individual. For discovery of SNP markers, sequencing analyses of the human CRTH2 gene were performed initially using pooled DNA samples from 10 randomly chosen subjects (see also Kwok et al 6 ) . Any sequence variants identified in this pool were then genotyped in the entire study population. A series of overlapping fragments (ranging Figure 1 Partial sequences of amplified products containing SNP#1 and #2 from three different genotypes as indicated. The sequences shown were sequenced using reverse primers. The sequences of PCR primers for genotypings are as follows: for SNP#1 and SNP#2, forward: 5Ј-AGCAGTGCTTCTCAAACCTTG, and reverse, 5Ј-CACTGCCCTAGAGTGGGAAG; for SNP#3 and #4, forward, 5Ј-AAAAAGGC TCGGGAAGGTTA, and reverse, 5Ј-GAGGCGCCTAAGTTGGAAGT. Based on GenBank sequence AF118265.
Genes and Immunity from 404 to 680 bp) encompassing 505 bp 5Ј-UTR, first exon (non-coding), second exon and 1602 bp 3Ј-UTR sequences were amplified by PCR, and the primers were designed based on the published DNA sequences (GenBank: AF118265 and XM006046). PCR was carried out in 25 l containing 10 mM Tris·HCl (pH 8.3), 50 mM KCl, 2.0 mM MgCl 2 , 200 M dNTPs, 0.3 units of Taq polymerase, and 4 pmol of each primer. PCR conditions consisted of an initial denaturation at 95°C for 5 min, followed by 30-40 cycles of denaturation at 95°C for 30 s, annealing at an optimized temperature between 55 and 65°C, for 30 s, and an extension at 72°C for 30 s, with a final extension at 72°C for 7 min. The PCR products were purified by QIAGEN PCR Purification Kit (Qiagen, Chatsworth, CA, USA), and sequenced directly on an ABI 377 DNA sequencer at the Genetics Resources Core Facility at Johns Hopkins University School of Medicine.
